LEMTRADA®
Administration of LEMTRADA® is intravenously infused over 4 hours for a 2 or more treatment course. First course consists of 12mg/ day for 5 consecutive days followed by 12mg/day on 3 consecutive days 12 months after the first course.
Administration and Dosage:
Administration of KRYSTEXXA® is by a bi-weekly intravenous infusion.
Indication:
Lemtrada® is indicated to treat:
- Forms of Relapsing Multiple Sclerosis
Common Side Effects:
The more common side effects of LEMTRADA® include serious autoimmune problems, serious infusion reactions, certain cancers, and stroke and tears in your arteries that supply blood to your brain (carotid and vertebral arteries).
More information:
Please read the full Prescribing Information and Medication Guide for LEMTRADA® and discuss any questions you have with your doctor.
HAVE QUESTIONS?
We are happy to help!
